Health and Healthcare

Merck : MRK

All Merck Articles

1096 Articles

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Aug 7, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Arconic, Boston Beer, Disney, Dunkin’, DuPont, GreenSky, IFF, Merck and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Arconic, Boston Beer, Dunkin' Brands, DuPont, GreenSky, International Flavors…

Chris Lange | Jul 30, 2019 at 9:40 AM EDT

Why Keytruda Made All the Difference in Merck’s Q2

Merck released better than expected second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jul 29, 2019 at 12:05 PM EDT

What to Watch When Merck and Pfizer Report Early on Tuesday

Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of…

Chris Lange | Jul 28, 2019 at 10:20 AM EDT

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, including…

Chris Lange | Jul 25, 2019 at 8:35 AM EDT

Short Sellers Up the Ante in Big Pharma

The July 15 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Jul 22, 2019 at 7:05 AM EDT

5 Merrill Lynch US 1 Stocks to Buy Also Pay Big and Growing Dividends

24/7 Wall St. screened the Merrill Lynch US 1 list looking for the stocks paying the highest dividends, as rates…

Chris Lange | Jul 11, 2019 at 9:45 AM EDT

Big Pharma Sees Rising Tide in Short Interest

The June 28 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jul 9, 2019 at 4:45 PM EDT

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

President Trump lost ground with his efforts to force drug companies to list drug prices on TV ads, with the…

Jon C. Ogg | Jul 3, 2019 at 9:00 AM EDT

Top Analyst Upgrades and Downgrades: Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec, Tesla and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras,…

Chris Lange | Jun 26, 2019 at 8:30 AM EDT

Short Sellers Seek Direction on Big Pharma

The June 14 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Jun 15, 2019 at 10:35 AM EDT

Our Top 10 Stock Moves & News Items for the Week

Top stock stories for the week of June 14, 2019 from earnings, mergers, analyst calls and more.

Jon C. Ogg | Jun 14, 2019 at 11:45 AM EDT

High Hopes and Expectations for Merck’s First Investor Day in Years

Merck is set to host its Investor Day on June 20. Investors will have a high bar of expectations because…

Chris Lange | Jun 12, 2019 at 8:30 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The May 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 16 17 18 19 20 … 74

Merck : MRK

All Merck Articles

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: Arconic, Boston Beer, Disney, Dunkin’, DuPont, GreenSky, IFF, Merck and More

Why Keytruda Made All the Difference in Merck’s Q2

What to Watch When Merck and Pfizer Report Early on Tuesday

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

Short Sellers Up the Ante in Big Pharma

5 Merrill Lynch US 1 Stocks to Buy Also Pay Big and Growing Dividends

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec, Tesla and More

Short Sellers Seek Direction on Big Pharma

Our Top 10 Stock Moves & News Items for the Week

High Hopes and Expectations for Merck’s First Investor Day in Years

Big Pharma Sees a Rising Tide in Short Interest

‘You Make $150,000 a Year and You’re Broke, That’s So Weird When You Say That Out Loud’: Ramsey to Caller With $95,000 in Debt

California Will Never Tax a Dime of Shohei Ohtani’s $680 Million. The Federal Law He’s Counting On Also Protects Your 401(k) the Day You Retire Across State Lines

He Booked $40,000 of Next Year’s Hunting Trips. Social Security Counted the Money Before He Saddled a Horse.

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

'You Make $150,000 a Year and You're Broke, That's So Weird When You Say That Out Loud': Ramsey to Caller With $95,000 in Debt

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

‘You Make $150,000 a Year and You’re Broke, That’s So Weird When You Say That Out Loud’: Ramsey to Caller With $95,000 in Debt

Merck : MRK

All Merck Articles

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: Arconic, Boston Beer, Disney, Dunkin’, DuPont, GreenSky, IFF, Merck and More

Why Keytruda Made All the Difference in Merck’s Q2

What to Watch When Merck and Pfizer Report Early on Tuesday

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

Short Sellers Up the Ante in Big Pharma

5 Merrill Lynch US 1 Stocks to Buy Also Pay Big and Growing Dividends

Big Pharma Sees Rising Tide in Short Interest

Many Top Pharma & Biotechs Rise as Drug Price Disclosure Thrown Out

Top Analyst Upgrades and Downgrades: Barrick Gold, CannTrust, Foot Locker, Inogen, L3Harris, Merck, Petrobras, Starbucks, Symantec, Tesla and More

Short Sellers Seek Direction on Big Pharma

Our Top 10 Stock Moves & News Items for the Week

High Hopes and Expectations for Merck’s First Investor Day in Years

Big Pharma Sees a Rising Tide in Short Interest

‘You Make $150,000 a Year and You’re Broke, That’s So Weird When You Say That Out Loud’: Ramsey to Caller With $95,000 in Debt

California Will Never Tax a Dime of Shohei Ohtani’s $680 Million. The Federal Law He’s Counting On Also Protects Your 401(k) the Day You Retire Across State Lines

He Booked $40,000 of Next Year’s Hunting Trips. Social Security Counted the Money Before He Saddled a Horse.

Featured Reads

His $5,000 Employer Disability Check Reduced His Social Security. Six Months Later, It Stopped Counting.

'You Make $150,000 a Year and You're Broke, That's So Weird When You Say That Out Loud': Ramsey to Caller With $95,000 in Debt